|
Delayed
OTC Markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | -99.33% |
| 08-06 | Morphic Medical Announces Board Appointments, Effective August 6, 2026 | CI |
| 08-03 | Morphic Medical Inc. Provides Update On Reset System Clinical And Commercial Progress | CI |
| Market Cap | 440K 379K 356K 325K 611K 41.91M 615K 4.22M 1.64M 21.25M 1.65M 1.62M 70.37M | P/E 2019 |
-1.12x | P/E 2020 | -0.03x |
|---|---|---|---|---|---|
| Enterprise Value | 3.28M 2.82M 2.65M 2.42M 4.55M 312M 4.58M 31.42M 12.22M 158M 12.31M 12.05M 524M | EV / Sales 2019 |
-
| EV / Sales 2020 | - |
| Free-Float |
-
| Yield 2019 * |
-
| Yield 2020 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Mike Gutteridge
CEO | Chief Executive Officer | - | 2025-08-04 |
Jane Wright
DFI | Director of Finance/CFO | 57 | 2025-07-31 |
| Chief Tech/Sci/R&D Officer | - | 2023-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Ginger Glaser
BRD | Director/Board Member | - | 2020-10-19 |
Alex Escalona
BRD | Director/Board Member | - | - |
John R. Barr
BRD | Director/Board Member | 69 | 2023-09-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/28/21 | Free | Chairman | 1,384,483 | 0.4875% | ||
| 1/28/21 | Free | Chief Executive Officer | 11,075,869 | 3.8998% |
| 2019 | 2020 | |
|---|---|---|
| Net sales | - | - |
| Net income | -17.33M -14.92M -14.01M -12.79M -24.03M -1.65B -24.2M -166M -64.61M -836M -65.08M -63.67M -2.77B | -11.14M -9.59M -9M -8.22M -15.44M -1.06B -15.55M -107M -41.51M -537M -41.81M -40.9M -1.78B |
| Net Debt | 2.89M 2.49M 2.33M 2.13M 4M 275M 4.03M 27.66M 10.76M 139M 10.84M 10.6M 461M | 2.84M 2.44M 2.3M 2.1M 3.94M 270M 3.96M 27.2M 10.58M 137M 10.66M 10.43M 454M |
Employees
-
Sector
-
- Stock Market
- Stocks
- GIDYL Stock
Select your edition
All financial news and data tailored to specific country editions
















